Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classement en actions #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prix de l'action
$71.46
Capitalisation boursière
$29.96B
Changement (1 jour)
-0.04%
Changement (1 an)
-51.01%
Pays
US
Échange Zoetis Inc. (ZTS)

Catégorie

Bénéfices pour Zoetis Inc. (ZTS)
Bénéfices en Jun 2026 TTM : $3.27B
Selon les derniers rapports financiers de Zoetis Inc., les bénéfices actuels de l'entreprise sont de $3.27B. En 2024, l'entreprise a réalisé un bénéfice de $3.13B, une augmentation par rapport à celui de 2023 qui était de $2.94B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Zoetis Inc. de 2009 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $3.27B -2.62%
2025 $3.36B 7.25%
2024 $3.13B 6.71%
2023 $2.94B 10.54%
2022 $2.66B 6.75%
2021 $2.49B 24.65%
2020 $2.00B 10.83%
2019 $1.80B 6.57%
2018 $1.69B 10.82%
2017 $1.53B 24.19%
2016 $1.23B 125.32%
2015 $545.00M -33.54%
2014 $820.00M 18.84%
2013 $690.00M -2.82%
2012 $710.00M 80.20%
2011 $394.00M 121.35%
2010 $178.00M -220.27%
2009 $-148.00M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$33.59B 926.72%
US
$25.20B 670.05%
US
$8.70B 165.86%
US
$21.39B 553.68%
CH
$5.95B 81.78%
US